Journal article
Heat shock protein complex vaccines induce antibodies against Neisseria meningitidis via a MyD88-independent mechanism
JX Han, GZ Ng, P Cecchini, YT Chionh, MA Saeed, LM Næss, M Joachim, LE Blandford, RA Strugnell, CA Colaco, P Sutton
Vaccine | ELSEVIER SCI LTD | Published : 2016
Abstract
Background: Neisseria meningitidis are common colonizers of the human nasopharynx. In some circumstances, N. meningitidis becomes an opportunistic pathogen that invades tissues and causes meningitis. While a vaccine against a number of serogroups has been in effective use for many years, a vaccine against N. meningitidis group B has not yet been universally adopted. Bacterial heat shock protein complex (HSPC) vaccines comprise bacterial HSPs, purified with their chaperoned protein cargo. HSPC vaccines use the intrinsic adjuvant activity of their HSP, thought to act via Toll-like receptors (TLR), to induce an immune response against their cargo antigens. This study evaluated HSPC vaccines fro..
View full abstractRelated Projects (2)
Grants
Awarded by Medical Research Council
Funding Acknowledgements
This work was supported by the Victorian Government's Operational Infrastructure Support Program, ARC Linkage Grant LP120100226 from the Australian Research Council and Immuno-Biology Limited. PS is supported by a Senior Research Fellowship from the National Health and Medical Research Council of Australia.